Homeopathy Sector Gains Momentum as Adven Biotech Secures NABL Accreditation
Adven Biotech Achieves NABL, Strengthening India’s Homeopathy Standards
First-of-its-Kind Accreditation
Adven Biotech has announced that it is the first homeopathy manufacturer in India to receive certification from the National Accreditation Board for Testing and Calibration Laboratories (NABL). This milestone reflects India’s growing focus on improving quality standards within the Ministry of AYUSH sector.
Supporting India’s Global Vision
The certification aligns with the broader vision of Narendra Modi to promote traditional systems of medicine as reliable and globally accepted healthcare solutions backed by scientific validation.
Raising Quality and Credibility
The NABL accreditation ensures that the company’s testing and quality control laboratories meet strict national and international standards. This step is expected to improve transparency, accuracy, and trust in homeopathic medicine manufacturing.
Boost for Global Expansion
With globally recognized certification in place, the company is better positioned to expand into international markets. It also strengthens confidence among doctors and patients, particularly in regions where quality assurance has been a concern.
Focus on Research and Innovation
The company continues to emphasize research-driven formulations, ethical practices, and advanced manufacturing systems. It had previously earned the Ayush Premium Mark, making it one of the few brands with multiple high-level certifications in the sector.
Industry Impact
Health experts believe that certifications like NABL are essential for reducing skepticism around alternative medicine. As India moves towards becoming a global AYUSH hub, such recognitions help establish homeopathy as standardized, evidence-based, and export-ready.
Source: economictimes.indiatimes
